Novo CEO pressed by Senate to cut selling prices of obesity, diabetic issues drugs CEO Lars Fruergaard Jørgensen advised lawmakers the company would think about new talks with insurers with regards to the listing prices of Wegovy and copyright whenever they pledge to keep the medicines on their formularies. Elevance https://buschlightpeachnutritionf07530.ssnblog.com/29996168/new-step-by-step-map-for-healthcare-news